RESUMEN
The 2nd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 03-05 November 2017 in Detroit, Michigan, USA. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF Inc.) founded in the USA, and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This was the second annual meeting of the SHSA with experts from different disciplines arriving from North America, Europe and Australia, in a joint aim to discuss most recent innovations, practical challenges and potential solutions to issues related in the management and care of Hidradenitis Suppurativa patients. The last session involved clinicians, patients and their families in an effort to educate them more about the disease.
Asunto(s)
Antiinfecciosos/uso terapéutico , Procedimientos Quirúrgicos Dermatologicos , Hidradenitis Supurativa/etiología , Hidradenitis Supurativa/terapia , Antiinflamatorios/uso terapéutico , Investigación Biomédica , Comorbilidad , Hidradenitis Supurativa/diagnóstico por imagen , Hidradenitis Supurativa/epidemiología , Humanos , Incidencia , Calidad de Vida , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , UltrasonografíaRESUMEN
Approximately 349 million individuals worldwide are actively infected with syphilis. The incidence of syphilis in North America and Europe is low but has been rising in recent years. The rate of concomitant infection with human immunodeficiency virus (HIV) and syphilis also has been increasing. Concomitant infection with HIV can cause syphilis to have atypical characteristics. These atypical findings can involve the skin as well as organs that rarely are affected in HIV-negative individuals such as the eyes. We present a case of syphilis causing palmoplantar keratoderma and ocular disease in a patient with HIV infection, and discuss the differences in diagnosis and treatment of patients with both diseases.